617 related articles for article (PubMed ID: 31231617)
1. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.
Ufermann CM; Domröse A; Babel T; Tersteegen A; Cengiz SC; Eller SK; Spekker-Bosker K; Sorg UR; Förster I; Däubener W
Front Cell Infect Microbiol; 2019; 9():184. PubMed ID: 31231617
[No Abstract] [Full Text] [Related]
2. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.
Fujigaki S; Saito K; Takemura M; Maekawa N; Yamada Y; Wada H; Seishima M
Infect Immun; 2002 Feb; 70(2):779-86. PubMed ID: 11796611
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
Fujigaki S; Takemura M; Hamakawa H; Seishima M; Saito K
Adv Exp Med Biol; 2003; 527():97-103. PubMed ID: 15206721
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.
Murakami Y; Hoshi M; Hara A; Takemura M; Arioka Y; Yamamoto Y; Matsunami H; Funato T; Seishima M; Saito K
Cytokine; 2012 Aug; 59(2):245-51. PubMed ID: 22609210
[TBL] [Abstract][Full Text] [Related]
5. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
Pfaff AW; Mousli M; Sénégas A; Marcellin L; Takikawa O; Klein JP; Candolfi E
Int J Parasitol; 2008 Feb; 38(2):249-58. PubMed ID: 17822706
[TBL] [Abstract][Full Text] [Related]
6. Huntingtons Disease Mice Infected with Toxoplasma gondii Demonstrate Early Kynurenine Pathway Activation, Altered CD8+ T-Cell Responses, and Premature Mortality.
Donley DW; Olson AR; Raisbeck MF; Fox JH; Gigley JP
PLoS One; 2016; 11(9):e0162404. PubMed ID: 27611938
[TBL] [Abstract][Full Text] [Related]
7.
Bando H; Lee Y; Sakaguchi N; Pradipta A; Sakamoto R; Tanaka S; Ma JS; Sasai M; Yamamoto M
Front Cell Infect Microbiol; 2019; 9():140. PubMed ID: 31119110
[No Abstract] [Full Text] [Related]
8. Indoleamine 2,3-Dioxygenase Activity in
Virok DP; Raffai T; Kókai D; Paróczai D; Bogdanov A; Veres G; Vécsei L; Poliska S; Tiszlavicz L; Somogyvári F; Endrész V; Burián K
Front Cell Infect Microbiol; 2019; 9():192. PubMed ID: 31249813
[No Abstract] [Full Text] [Related]
9. Tryptophan-kynurenine pathway attenuates β-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in Toxoplasma gondii infection.
Majumdar T; Sharma S; Kumar M; Hussain MA; Chauhan N; Kalia I; Sahu AK; Rana VS; Bharti R; Haldar AK; Singh AP; Mazumder S
Cell Death Dis; 2019 Feb; 10(3):161. PubMed ID: 30770800
[TBL] [Abstract][Full Text] [Related]
10.
Bando H; Sakaguchi N; Lee Y; Pradipta A; Ma JS; Tanaka S; Lai DH; Liu J; Lun ZR; Nishikawa Y; Sasai M; Yamamoto M
Front Immunol; 2018; 9():2073. PubMed ID: 30283439
[No Abstract] [Full Text] [Related]
11. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.
Silva NM; Rodrigues CV; Santoro MM; Reis LF; Alvarez-Leite JI; Gazzinelli RT
Infect Immun; 2002 Feb; 70(2):859-68. PubMed ID: 11796621
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Host Defense Mechanisms against Toxoplasma gondii Infection in Anhedonic and Despair-Like Behaviors in Mice.
Mahmoud ME; Fereig R; Nishikawa Y
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138019
[No Abstract] [Full Text] [Related]
13. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches.
Prandota J
Am J Ther; 2007; 14(1):63-105. PubMed ID: 17303977
[TBL] [Abstract][Full Text] [Related]
14. Role of IDO activation in anti-microbial defense in human native astrocytes.
Oberdörfer C; Adams O; MacKenzie CR; De Groot CJ; Däubener W
Adv Exp Med Biol; 2003; 527():15-26. PubMed ID: 15206712
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.
Nagineni CN; Pardhasaradhi K; Martins MC; Detrick B; Hooks JJ
Infect Immun; 1996 Oct; 64(10):4188-96. PubMed ID: 8926087
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in indoleamine-2, 3-dioxygenase induces upregulation of guanylate binding protein 1 and inducible nitric oxide synthase expression in the brain during cerebral infection with Toxoplasma gondii in genetically resistant BALB/c mice but not in genetically susceptible C57BL/6 mice.
Anand N; Lutshumba J; Whitlow M; Abdelaziz MH; Mani R; Suzuki Y
Microbes Infect; 2022; 24(3):104908. PubMed ID: 34781010
[TBL] [Abstract][Full Text] [Related]
17. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages.
Lüder CG; Algner M; Lang C; Bleicher N; Gross U
Int J Parasitol; 2003 Jul; 33(8):833-44. PubMed ID: 12865083
[TBL] [Abstract][Full Text] [Related]
19. Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.
Jackman KA; Brait VH; Wang Y; Maghzal GJ; Ball HJ; McKenzie G; De Silva TM; Stocker R; Sobey CG
Naunyn Schmiedebergs Arch Pharmacol; 2011 May; 383(5):471-81. PubMed ID: 21359968
[TBL] [Abstract][Full Text] [Related]
20. Recombinant
Czarnewski P; Araújo ECB; Oliveira MC; Mineo TWP; Silva NM
Front Cell Infect Microbiol; 2017; 7():142. PubMed ID: 28487847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
